Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bharti Mackness

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Lipid Research|February 22, 2011
Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based studyGerard Aragonès, Marta Guardiola, María Barreda, et al.
Circulation|April 2, 2003
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosisAnn Mertens, Peter Verhamme, John K Bielicki, et al.
Disease Markers|August 1, 2012
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT studyBharti Mackness, Judit Marsillach, Robert S Elkeles, et al.
Human & Experimental Toxicology|December 23, 2003
Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposureAntonio F Hernández, Bharti Mackness, Lourdes Rodrigo, et al.
Clinical Biochemistry|September 14, 2013
Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndromeNatàlia Ferré, Albert Feliu, Anabel García-Heredia, et al.
Clinical Endocrinology|December 8, 2004
Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapySee Kwok, Peter L Selby, Patrick McElduff, et al.
Clinical Biochemistry|August 23, 2011
Serum paraoxonase-3 concentration is associated with the severity of hepatic impairment in patients with chronic liver diseaseAnabel García-Heredia, Judit Marsillach, Gerard Aragonès, et al.
European Journal of Clinical Investigation|October 23, 2010
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaquesJudit Marsillach, Jordi Camps, Raul Beltran-Debón, et al.
Journal of Occupational and Environmental Medicine|July 12, 2003
Paraoxonase in Persian Gulf War veteransMatthew Hotopf, Michael Ian Mackness, Vasilis Nikolaou, et al.
Clinical Biochemistry|March 6, 2007
Serum paraoxonase-1 in chronic alcoholics: relationship with liver diseaseJudit Marsillach, Natàlia Ferré, Maria C Vila, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Lipid Research|February 22, 2011
Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based studyGerard Aragonès, Marta Guardiola, María Barreda, et al.
Circulation|April 2, 2003
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosisAnn Mertens, Peter Verhamme, John K Bielicki, et al.
Disease Markers|August 1, 2012
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: results from the PREDICT studyBharti Mackness, Judit Marsillach, Robert S Elkeles, et al.
Human & Experimental Toxicology|December 23, 2003
Paraoxonase activity and genetic polymorphisms in greenhouse workers with long term pesticide exposureAntonio F Hernández, Bharti Mackness, Lourdes Rodrigo, et al.
Clinical Biochemistry|September 14, 2013
Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndromeNatàlia Ferré, Albert Feliu, Anabel García-Heredia, et al.
Clinical Endocrinology|December 8, 2004
Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapySee Kwok, Peter L Selby, Patrick McElduff, et al.
Clinical Biochemistry|August 23, 2011
Serum paraoxonase-3 concentration is associated with the severity of hepatic impairment in patients with chronic liver diseaseAnabel García-Heredia, Judit Marsillach, Gerard Aragonès, et al.
European Journal of Clinical Investigation|October 23, 2010
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaquesJudit Marsillach, Jordi Camps, Raul Beltran-Debón, et al.
Journal of Occupational and Environmental Medicine|July 12, 2003
Paraoxonase in Persian Gulf War veteransMatthew Hotopf, Michael Ian Mackness, Vasilis Nikolaou, et al.
Clinical Biochemistry|March 6, 2007
Serum paraoxonase-1 in chronic alcoholics: relationship with liver diseaseJudit Marsillach, Natàlia Ferré, Maria C Vila, et al.
Pageof 6